Hoda Borooghani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hoda Borooghani has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Kavous Firouznia
Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Narges Azizi
Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Shahriar Kolahi
Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Taghi Aghajanlou
Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 shared publications - Zeinab Gharaylou
Shefa Neuroscience Research Center, Tehran, Iran
2 shared publications - Ahmadreza Sohrabi-Ashlaghi
Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences (TUMS), Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 20 September 2026
- Published by Wiley in Human Brain Mapping
- Vol. 47 (14) , e70649
DTI ‐ ALPS as a Biomarker of Small Vessel Disease Progression and Amyloid‐β in Normal Aging: A 3‐Year Longitudinal Study
Cerebral small vessel disease (SVD) is a leading cause of stroke, vascular cognitive impairment, and functional decline in older adults. Emerging experimental and translational data implicate glymphatic dysfunction in SVD pathogenesis and in vascular amyloid accumulation. The analysis along the perivascular space (ALPS) index, derived from diffusion tensor imaging (DTI), noninvasively estimates water diffusivity along perivascular pathways and has been proposed as an indirect imaging marker related to glymphatic function. In this study, we aim to determine whether the baseline DTI‐ALPS index is associated with baseline SVD burden and subsequent longitudinal changes in SVD markers and amyloid‐β deposition in cognitively normal aging. We analyzed 204 cognitively normal participants from the Harvard Aging Brain Study with baseline and follow‐up visits separated by 3 years. Primary MRI SVD outcomes were intracranial‐volume–normalized white matter hyperintensities (WMH/ICV), and visual SVD ratings (Fazekas, ARWMC, perivascular space, and BOMBS [microbleed scale]). Secondary outcomes included cortical amyloid PET burden (PIB_FS_DVR_FLR). We tested the effects of time, baseline ALPS ( z ‐scored), and the time‐ALPS interaction using Bayesian mixed‐effects models with subject‐specific random intercepts adjusted for baseline age, sex, and education; amyloid models were additionally adjusted for APOE4 status. Continuous outcomes were modeled with Gaussian mixed‐effects models, binary outcomes with Bernoulli mixed‐effects models, and ordinal outcomes with Bayesian cumulative mixed‐effects models. In a sensitivity analysis, ALPS was recalculated after excluding voxels with λ 2 / λ 3 > 1.8, and the models were repeated using the crossing‐fiber‐adjusted index. Posterior means and 95% HDIs were the primary summaries. Multiplicity was controlled using the Benjamini–Hochberg false discovery rate procedure, and the resulting FDR‐adjusted two‐sided posterior tail‐area p ‐analogues are reported as p corrected . Over the 3‐year follow‐up, SVD and amyloid‐β burden increased: WMH/ICV ( β = 0.096, 95% HDI [0.069, 0.121], p corrected < 0.001), cortical amyloid‐β ( β = 0.130, 95% HDI [0.106, 0.152], p corrected < 0.001), Fazekas ( β = 0.320, 95% HDI [0.088, 0.541], p corrected = 0.010), ARWMC ( β = 0.404, 95% HDI [0.165, 0.649], p corrected = 0.004), basal ganglia ( β = 0.318, 95% HDI [0.079, 0.546], p corrected = 0.010), and centrum semiovale ( β = 0.244, 95% HDI [0.026, 0.450], p corrected = 0.025). PVS scores also increased over time. Higher baseline ALPS was associated with lower Fazekas severity ( β = −0.742, 95% HDI [−1.281, −0.201], p corrected = 0.026) and with attenuated amyloid accumulation over time ( β = −0.025, 95% HDI [−0.049, −0.001], p corrected = 0.039). In a sensitivity analysis excluding voxels with a high likelihood of substantial fiber crossing, the ALPS‐by‐time interaction for amyloid burden remained significant ( β = −0.028, 95% HDI [−0.052, −0.003], p corrected = 0.022), whereas the baseline association with Fazekas severity was attenuated ( β = −0.413, 95% HDI [−0.966, 0.181], p corrected = 0.751). Higher baseline WMH/ICV was associated with poorer baseline global cognition (PACC5) ( β = −0.092, 95% HDI [−0.177, −0.011], p corrected = 0.036), processing speed ( β = −0.116, 95% HDI [−0.223, −0.010], p corrected = 0.036), and executive function ( β = −0.144, 95% HDI [−0.251, −0.029], p corrected = 0.035). Higher baseline amyloid burden was associated with steeper PACC5 decline ( β = −0.065, 95% HDI [−0.096, −0.033], p corrected < 0.001). In cognitively normal older adults, higher conventional baseline ALPS was associated with lower Fazekas severity, although attenuation after crossing‐fiber adjustment indicates that this cross‐sectional relationship was sensitive to the microstructural composition of the ALPS regions. In contrast, higher baseline ALPS was associated with slower short‐term amyloid‐β accumulation, and this longitudinal association remained significant after crossing‐fiber adjustment. Greater baseline amyloid burden was associated with more rapid decline in global cognition, whereas higher baseline WMH volume was associated with poorer baseline global cognition, processing speed, and executive function. These findings support ALPS as a candidate noninvasive diffusion marker associated with longitudinal amyloid‐related change, while emphasizing the need for further validation of its relationship with SVD burden and its biological specificity.
- 20 September 2026
- Published by Wiley in Human Brain Mapping
- Vol. 47 (14) , e70649
Open AccessDTI ‐ ALPS as a Biomarker of Small Vessel Disease Progression and Amyloid‐β in Normal Aging: A 3‐Year Longitudinal Study
Cerebral small vessel disease (SVD) is a leading cause of stroke, vascular cognitive impairment, and functional decline in older adults. Emerging experimental and translational data implicate glymphatic dysfunction in SVD pathogenesis and in vascular amyloid accumulation. The analysis along the perivascular space (ALPS) index, derived from diffusion tensor imaging (DTI), noninvasively estimates water diffusivity along perivascular pathways and has been proposed as an indirect imaging marker related to glymphatic function. In this study, we aim to determine whether the baseline DTI‐ALPS index is associated with baseline SVD burden and subsequent longitudinal changes in SVD markers and amyloid‐β deposition in cognitively normal aging. We analyzed 204 cognitively normal participants from the Harvard Aging Brain Study with baseline and follow‐up visits separated by 3 years. Primary MRI SVD outcomes were intracranial‐volume–normalized white matter hyperintensities (WMH/ICV), and visual SVD ratings (Fazekas, ARWMC, perivascular space, and BOMBS [microbleed scale]). Secondary outcomes included cortical amyloid PET burden (PIB_FS_DVR_FLR). We tested the effects of time, baseline ALPS ( z ‐scored), and the time‐ALPS interaction using Bayesian mixed‐effects models with subject‐specific random intercepts adjusted for baseline age, sex, and education; amyloid models were additionally adjusted for APOE4 status. Continuous outcomes were modeled with Gaussian mixed‐effects models, binary outcomes with Bernoulli mixed‐effects models, and ordinal outcomes with Bayesian cumulative mixed‐effects models. In a sensitivity analysis, ALPS was recalculated after excluding voxels with λ 2 / λ 3 > 1.8, and the models were repeated using the crossing‐fiber‐adjusted index. Posterior means and 95% HDIs were the primary summaries. Multiplicity was controlled using the Benjamini–Hochberg false discovery rate procedure, and the resulting FDR‐adjusted two‐sided posterior tail‐area p ‐analogues are reported as p corrected . Over the 3‐year follow‐up, SVD and amyloid‐β burden increased: WMH/ICV ( β = 0.096, 95% HDI [0.069, 0.121], p corrected < 0.001), cortical amyloid‐β ( β = 0.130, 95% HDI [0.106, 0.152], p corrected < 0.001), Fazekas ( β = 0.320, 95% HDI [0.088, 0.541], p corrected = 0.010), ARWMC ( β = 0.404, 95% HDI [0.165, 0.649], p corrected = 0.004), basal ganglia ( β = 0.318, 95% HDI [0.079, 0.546], p corrected = 0.010), and centrum semiovale ( β = 0.244, 95% HDI [0.026, 0.450], p corrected = 0.025). PVS scores also increased over time. Higher baseline ALPS was associated with lower Fazekas severity ( β = −0.742, 95% HDI [−1.281, −0.201], p corrected = 0.026) and with attenuated amyloid accumulation over time ( β = −0.025, 95% HDI [−0.049, −0.001], p corrected = 0.039). In a sensitivity analysis excluding voxels with a high likelihood of substantial fiber crossing, the ALPS‐by‐time interaction for amyloid burden remained significant ( β = −0.028, 95% HDI [−0.052, −0.003], p corrected = 0.022), whereas the baseline association with Fazekas severity was attenuated ( β = −0.413, 95% HDI [−0.966, 0.181], p corrected = 0.751). Higher baseline WMH/ICV was associated with poorer baseline global cognition (PACC5) ( β = −0.092, 95% HDI [−0.177, −0.011], p corrected = 0.036), processing speed ( β = −0.116, 95% HDI [−0.223, −0.010], p corrected = 0.036), and executive function ( β = −0.144, 95% HDI [−0.251, −0.029], p corrected = 0.035). Higher baseline amyloid burden was associated with steeper PACC5 decline ( β = −0.065, 95% HDI [−0.096, −0.033], p corrected < 0.001). In cognitively normal older adults, higher conventional baseline ALPS was associated with lower Fazekas severity, although attenuation after crossing‐fiber adjustment indicates that this cross‐sectional relationship was sensitive to the microstructural composition of the ALPS regions. In contrast, higher baseline ALPS was associated with slower short‐term amyloid‐β accumulation, and this longitudinal association remained significant after crossing‐fiber adjustment. Greater baseline amyloid burden was associated with more rapid decline in global cognition, whereas higher baseline WMH volume was associated with poorer baseline global cognition, processing speed, and executive function. These findings support ALPS as a candidate noninvasive diffusion marker associated with longitudinal amyloid‐related change, while emphasizing the need for further validation of its relationship with SVD burden and its biological specificity.
- Open Access
- 1 December 2025
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 18, 3571-3578
An Atypical Female Case of Ichthyosis Follicularis, Alopecia, and Photophobia (IFAP) Syndrome with Severe Lower Limb Contractures Requiring Orthopedic Surgery
Background: Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome is a rare X-linked genodermatosis with follicular hyperkeratosis, non-scarring alopecia, and ocular abnormalities. Female cases are very uncommon and typically manifest with a milder phenotype, though severe presentations can occur. Orthopedic complications are not commonly described in IFAP. Case Presentation: We present a 10-year-old girl with congenital alopecia and diffuse follicular hyperkeratosis who, despite lacking photophobia, progressed to develop flexion contractures of the knees and equinus deformities of the ankles, resulting in marked restriction of mobility. Ophthalmological examination demonstrated mild astigmatism and decreased visual acuity without corneal disease. Skin biopsy histopathology demonstrated orthokeratotic hyperkeratosis, acanthosis, and follicular plugging, which was in line with IFAP syndrome. The patient underwent posterior soft tissue release of the knees and Achilles tendon lengthening, which led to marked postoperative functional improvement in ambulation. Conclusion: This case expands the phenotypic range of IFAP syndrome by describing a non-classical female presentation with no photophobia but with extreme musculoskeletal contractures requiring surgery. It emphasizes the need for early identification and multidisciplinary treatment, such as orthopedic intervention, to avert long-term disability and enhance the quality of life. Plain Language Summary: Ichthyosis follicularis, alopecia, and photophobia syndrome (IFAP) is an uncommon genetic condition that affects the skin, hair, and eye tissues predominantly. It is usually seen in males, as the syndrome is linked with the presence of the X chromosome. In this report we describe a unique case of a 10-year-old girl. At birth, she had a complete baldness on the scalp, eyebrows, and eyelashes, and had coarse, thickened epidermic skin over her entire body. Differently from the rest of the IFAP patients, she never had intolerance to light (photophobia). With increasing age, she developed extensive stiffness and contractures in the legs, making it impossible for her to walk. After several assessments, the diagnosis of IFAP syndrome was confirmed through skin biopsy. The patient was then treated with orthopedic surgery that relaxed tightened tissues in her legs and lengthened her Achilles tendons, followed by a physiotherapy protocol. These treatments led to better leg positioning as well as increased autonomy in her walking functions. This case is useful as one that demonstrates that IFAP syndrome is possible in females and that the presentation can be unusual compared with the typical form. It further indicates the importance of a team, including dermatologists, orthopedic surgeons, and rehab specialists, working in unison. Prompt diagnosis and collaborative care can very much enhance the quality of life and functioning in patients with this rare disease.
- 1 December 2025
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 18, 3571-3578
Open AccessAn Atypical Female Case of Ichthyosis Follicularis, Alopecia, and Photophobia (IFAP) Syndrome with Severe Lower Limb Contractures Requiring Orthopedic Surgery
Background: Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome is a rare X-linked genodermatosis with follicular hyperkeratosis, non-scarring alopecia, and ocular abnormalities. Female cases are very uncommon and typically manifest with a milder phenotype, though severe presentations can occur. Orthopedic complications are not commonly described in IFAP. Case Presentation: We present a 10-year-old girl with congenital alopecia and diffuse follicular hyperkeratosis who, despite lacking photophobia, progressed to develop flexion contractures of the knees and equinus deformities of the ankles, resulting in marked restriction of mobility. Ophthalmological examination demonstrated mild astigmatism and decreased visual acuity without corneal disease. Skin biopsy histopathology demonstrated orthokeratotic hyperkeratosis, acanthosis, and follicular plugging, which was in line with IFAP syndrome. The patient underwent posterior soft tissue release of the knees and Achilles tendon lengthening, which led to marked postoperative functional improvement in ambulation. Conclusion: This case expands the phenotypic range of IFAP syndrome by describing a non-classical female presentation with no photophobia but with extreme musculoskeletal contractures requiring surgery. It emphasizes the need for early identification and multidisciplinary treatment, such as orthopedic intervention, to avert long-term disability and enhance the quality of life. Plain Language Summary: Ichthyosis follicularis, alopecia, and photophobia syndrome (IFAP) is an uncommon genetic condition that affects the skin, hair, and eye tissues predominantly. It is usually seen in males, as the syndrome is linked with the presence of the X chromosome. In this report we describe a unique case of a 10-year-old girl. At birth, she had a complete baldness on the scalp, eyebrows, and eyelashes, and had coarse, thickened epidermic skin over her entire body. Differently from the rest of the IFAP patients, she never had intolerance to light (photophobia). With increasing age, she developed extensive stiffness and contractures in the legs, making it impossible for her to walk. After several assessments, the diagnosis of IFAP syndrome was confirmed through skin biopsy. The patient was then treated with orthopedic surgery that relaxed tightened tissues in her legs and lengthened her Achilles tendons, followed by a physiotherapy protocol. These treatments led to better leg positioning as well as increased autonomy in her walking functions. This case is useful as one that demonstrates that IFAP syndrome is possible in females and that the presentation can be unusual compared with the typical form. It further indicates the importance of a team, including dermatologists, orthopedic surgeons, and rehab specialists, working in unison. Prompt diagnosis and collaborative care can very much enhance the quality of life and functioning in patients with this rare disease.
- Open Access
- 30 November 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (12)
Primary Limb Leiomyosarcoma With Multifocal Musculoskeletal Soft Tissue Metastasis: A Case Report and Literature Review
Leiomyosarcoma (LMS) is an aggressive soft‐tissue sarcoma that may rarely arise in the extremities and metastasize to multiple organs. Primary bone LMS is extremely uncommon and often misdiagnosed due to nonspecific symptoms like pain and swelling. Diagnosis relies on histopathology and immunohistochemistry. Treatment focuses on surgical resection, with chemotherapy and radiotherapy for advanced disease. LMS has a poor prognosis with frequent metastasis, requiring a multidisciplinary approach. A 49‐year‐old man presented with persistent right knee pain following a fall. Initial imaging suggested a benign lesion, but further investigation due to persistent symptoms led to a malignant spindle‐cell tumor diagnosed by biopsy, later confirmed as Grade II leiomyosarcoma (LMS) through immunohistochemistry. After wide surgical excision and radiotherapy, initial follow‐up showed no metastases. However, over the following year, imaging detected liver lesions, lung nodules, and a paraspinal mass (indicative of metastatic spread). The patient received chemotherapy but discontinued follow‐up for a year, during which the liver masses grew. Biopsy confirmed metastatic LMS, and further chemotherapy was administered. Subsequent scans showed partial response, and surgical removal of liver and paraspinal masses was recommended. The paraspinal mass was excised in early 2024 and confirmed as metastatic LMS. At the latest follow‐up, the patient's knee was stable, lungs were clear, and liver lesions were controlled, though he continued to experience pelvic paresthesia and ankle congestion. Ongoing symptoms and the tumor's recurrent nature underline the need for continuous monitoring. The case reflects the importance of an initial multidisciplinary approach and aggressive management to improve outcomes. Due to LMS's rarity and varied presentation, more case reports are essential to better understand its metastatic behavior, improve early detection, and guide treatment strategies. This case contributes valuable insights to the limited literature on metastatic extremity LMS.
- 30 November 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (12)
Open AccessPrimary Limb Leiomyosarcoma With Multifocal Musculoskeletal Soft Tissue Metastasis: A Case Report and Literature Review
Leiomyosarcoma (LMS) is an aggressive soft‐tissue sarcoma that may rarely arise in the extremities and metastasize to multiple organs. Primary bone LMS is extremely uncommon and often misdiagnosed due to nonspecific symptoms like pain and swelling. Diagnosis relies on histopathology and immunohistochemistry. Treatment focuses on surgical resection, with chemotherapy and radiotherapy for advanced disease. LMS has a poor prognosis with frequent metastasis, requiring a multidisciplinary approach. A 49‐year‐old man presented with persistent right knee pain following a fall. Initial imaging suggested a benign lesion, but further investigation due to persistent symptoms led to a malignant spindle‐cell tumor diagnosed by biopsy, later confirmed as Grade II leiomyosarcoma (LMS) through immunohistochemistry. After wide surgical excision and radiotherapy, initial follow‐up showed no metastases. However, over the following year, imaging detected liver lesions, lung nodules, and a paraspinal mass (indicative of metastatic spread). The patient received chemotherapy but discontinued follow‐up for a year, during which the liver masses grew. Biopsy confirmed metastatic LMS, and further chemotherapy was administered. Subsequent scans showed partial response, and surgical removal of liver and paraspinal masses was recommended. The paraspinal mass was excised in early 2024 and confirmed as metastatic LMS. At the latest follow‐up, the patient's knee was stable, lungs were clear, and liver lesions were controlled, though he continued to experience pelvic paresthesia and ankle congestion. Ongoing symptoms and the tumor's recurrent nature underline the need for continuous monitoring. The case reflects the importance of an initial multidisciplinary approach and aggressive management to improve outcomes. Due to LMS's rarity and varied presentation, more case reports are essential to better understand its metastatic behavior, improve early detection, and guide treatment strategies. This case contributes valuable insights to the limited literature on metastatic extremity LMS.
- Open Access
- 13 October 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 35636
Structural and diffusion imaging in olfactory-related brain regions in Parkinson’s disease: predictors of clinical progression
Olfactory dysfunction is a prevalent non-motor symptom in Parkinson’s disease (PD). Structural and diffusion MRI studies suggest that olfactory-related brain regions undergo significant neurodegenerative changes in PD. The current study aims to explore the longitudinal structural and diffusion imaging in olfactory-related regions in PD over four years. The relationships between baseline imaging and fluid biomarkers, and subsequent cognitive and clinical changes were also explored. We analyzed 97 newly diagnosed early-stage PD patients from the Parkinson’s Progression Markers Initiative (PPMI) who underwent T1-weighted MRI, diffusion tensor imaging (DTI), and clinical assessments at baseline, two years, and four years. Structural and diffusion measures of olfactory-related regions were extracted using FreeSurfer and ExploreDTI. Baseline fluid biomarkers were also evaluated. Baseline mean diffusivity (MD) displayed significant associations with further cognitive changes across multiple regions, including amygdala, orbitofrontal cortex (OFC), insula, and thalamus (β=–0.214 to − 0.422). Baseline structural measures, including amygdala volume and entorhinal and OFC thickness, were associated with subsequent changes in cognitive and Unified Parkinson’s Disease Rating Scale (UPDRS) scores (β = 0.264 to 0.402). Moreover, baseline serum neurofilament-light chain levels predicted multiple cognitive score changes (β= − 0.603 to − 0.331). Longitudinal analyses revealed a significant MD increase in the thalamus along with gradual reductions in volume and cortical thickness in the amygdala, insula, OFC, and entorhinal cortex (FDR-adjusted p < 0.05). Linear mixed-effect models further confirmed thalamic diffusion metrics as a predictor of cognitive deterioration. Olfactory-related regions exhibit progressive neurodegeneration in early PD, contributing to worsening cognition and disease severity. Baseline imaging and fluid biomarkers may serve as prognostic tools in PD.
- 13 October 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 35636
Open AccessStructural and diffusion imaging in olfactory-related brain regions in Parkinson’s disease: predictors of clinical progression
Olfactory dysfunction is a prevalent non-motor symptom in Parkinson’s disease (PD). Structural and diffusion MRI studies suggest that olfactory-related brain regions undergo significant neurodegenerative changes in PD. The current study aims to explore the longitudinal structural and diffusion imaging in olfactory-related regions in PD over four years. The relationships between baseline imaging and fluid biomarkers, and subsequent cognitive and clinical changes were also explored. We analyzed 97 newly diagnosed early-stage PD patients from the Parkinson’s Progression Markers Initiative (PPMI) who underwent T1-weighted MRI, diffusion tensor imaging (DTI), and clinical assessments at baseline, two years, and four years. Structural and diffusion measures of olfactory-related regions were extracted using FreeSurfer and ExploreDTI. Baseline fluid biomarkers were also evaluated. Baseline mean diffusivity (MD) displayed significant associations with further cognitive changes across multiple regions, including amygdala, orbitofrontal cortex (OFC), insula, and thalamus (β=–0.214 to − 0.422). Baseline structural measures, including amygdala volume and entorhinal and OFC thickness, were associated with subsequent changes in cognitive and Unified Parkinson’s Disease Rating Scale (UPDRS) scores (β = 0.264 to 0.402). Moreover, baseline serum neurofilament-light chain levels predicted multiple cognitive score changes (β= − 0.603 to − 0.331). Longitudinal analyses revealed a significant MD increase in the thalamus along with gradual reductions in volume and cortical thickness in the amygdala, insula, OFC, and entorhinal cortex (FDR-adjusted p < 0.05). Linear mixed-effect models further confirmed thalamic diffusion metrics as a predictor of cognitive deterioration. Olfactory-related regions exhibit progressive neurodegeneration in early PD, contributing to worsening cognition and disease severity. Baseline imaging and fluid biomarkers may serve as prognostic tools in PD.